Safinamide tatoside A InChiKey: HVXKQKFEHMGHSL-GOOCMWNKSA-N

InChiKey: HVXKQKFEHMGHSL-GOOCMWNKSA-N

reparixin alone or in combination with docetaxel reduced tumor growth compared with saline control

InChiKey: KWJRSHZSULRJHE-UHFFFAOYSA-N

PubMed PMID: 24179414

TAK-779 did not affect production of IL-12 by antigen-presenting cells

Safinamide tatoside A InChiKey: HVXKQKFEHMGHSL-GOOCMWNKSA-NSafinamide, also known as FCE 26743 and EMD 1195686, is a drug indicated for the treatment of Parkinson's disease with multiple methods of action. Potential additional uses might be restless legs syndrome (RLS) and epilepsy. Safinamide is a reversible and selective monoamine oxidase B inhibitor, reducing degradation of dopamine, and a glutamate release inhibitor. It also inhibits dopamine reuptake. Additionally, safinamide blocks sodium and calcium